NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY TO DESCRIBE USE BY INDICATION AND CLINICAL OUTCOMES AMONG PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTION OR COMPLICATED SKIN AND SOFT TISSUE INFECTION TREATED WITH TIGECYCLINE (TYGACIL®) IN THE EUROPEAN UNION